190
Views
0
CrossRef citations to date
0
Altmetric
Notes

Streptothiazolidine B, a new cytotoxic alkaloid produced by Streptomyces violaceoruber

, , , , , , & show all
Pages 595-602 | Received 02 Jun 2022, Accepted 07 Aug 2022, Published online: 24 Aug 2022
 

Abstract

A new cytotoxic alkaloid, named streptothiazolidine B (1), together with three known compounds (2-4), were isolated from Streptomyces violaceoruber. The structure of the undescribed compound was established using 1D and 2D NMR, and HRESIMS. Streptothiazolidine B was isolated and identified as an amide alkaloid with a unique thiazolidine side chain and its absolute configuration was determined by a combination of NOESY experiment and ECD analysis. Streptothiazolidine B exhibited significant cytotoxic activities against two human tumor cell lines, Li-7 and A2780, with IC50 values of 7.8, and 9.1 μM. Meanwhile, compound 4 showed obvious cytotoxic activities against four human tumor cell lines, THP-1, HT29, Li-7 and A2780, with IC50 values ranging from 3.1 to 10.2 μM.

Acknowledgments

This research was financially supported by the National Natural Science Foundation of China under Grant (numbers 32160019); Spring City Project (C201914001); Yunnan Applied Basic Research Program University Joint General Fund Project (2018FH001-003,202001BA070001-028,043).

Disclosure statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Additional information

Funding

This work was supported by National Natural Science Foundation of China under Grant number [32160019]; Spring City Project (C201914001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.